These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1892368)

  • 41. Short-term memory in Parkinson's disease after withdrawal of long-term anticholinergic therapy.
    van Herwaarden G; Berger HJ; Horstink MW
    Clin Neuropharmacol; 1993 Oct; 16(5):438-43. PubMed ID: 8221704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Memory disturbances in Parkinson's disease].
    Ringendahl H
    Fortschr Neurol Psychiatr; 1996 Feb; 64(2):43-8. PubMed ID: 8851378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recognition memory in Parkinson's disease.
    Flowers KA; Pearce I; Pearce JM
    J Neurol Neurosurg Psychiatry; 1984 Nov; 47(11):1174-81. PubMed ID: 6502175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The on-off effect - a side-effect of long-term levodopa treatment.
    Stern G; Lees A
    Nurs Mirror; 1978 Aug; 147(7):17-8. PubMed ID: 249490
    [No Abstract]   [Full Text] [Related]  

  • 45. Cognitive fluctuations associated with on-off phenomenon in Parkinson disease.
    Delis D; Direnfeld L; Alexander MP; Kaplan E
    Neurology; 1982 Sep; 32(9):1049-52. PubMed ID: 7202159
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of task complexity on reaction times in memory scanning and visual discrimination in Parkinson's disease.
    Russ MO; Seger L
    Neuropsychologia; 1995 May; 33(5):561-75. PubMed ID: 7637853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High speed memory scanning in parkinsonism.
    Wilson RS; Kaszniak AW; Klawans HL; Garron DC
    Cortex; 1980 Mar; 16(1):67-72. PubMed ID: 7379568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relations between on-off phenomena and cognitive functions in Parkinson disease.
    Meco G; Bonifati V; Bedini L; Bellatreccia A; Vanacore N; Franzese A
    Ital J Neurol Sci; 1991 Feb; 12(1):57-62. PubMed ID: 2013525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive concomitants of dopamine system stimulation in parkinsonian patients.
    Mohr E; Fabbrini G; Ruggieri S; Fedio P; Chase TN
    J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1192-6. PubMed ID: 3668568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spatial and non-spatial working memory at different stages of Parkinson's disease.
    Owen AM; Iddon JL; Hodges JR; Summers BA; Robbins TW
    Neuropsychologia; 1997 Apr; 35(4):519-32. PubMed ID: 9106280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test.
    Pillon B; Dubois B; Bonnet AM; Esteguy M; Guimaraes J; Vigouret JM; Lhermitte F; Agid Y
    Neurology; 1989 Jun; 39(6):762-8. PubMed ID: 2725868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure of a peripheral dopaminergic marker in Parkinson's disease.
    Maloteaux JM; Laterre CE; Hens L; Laduron PM
    J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1146-8. PubMed ID: 6663315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parkinson's disease affects automatic and spares intentional verbal learning. A stochastic approach to explicit learning processes.
    Faglioni P; Scarpa M; Botti C; Ferrari V
    Cortex; 1995 Dec; 31(4):597-617. PubMed ID: 8750021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed recognition memory in Parkinson's disease: a role for working memory?
    Stebbins GT; Gabrieli JD; Masciari F; Monti L; Goetz CG
    Neuropsychologia; 1999 Apr; 37(4):503-10. PubMed ID: 10215097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does old age or Parkinson's disease cause bradyphrenia?
    Phillips JG; Schiffter T; Nicholls ME; Bradshaw JL; Iansek R; Saling LL
    J Gerontol A Biol Sci Med Sci; 1999 Aug; 54(8):M404-9. PubMed ID: 10496546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunction.
    Malapani C; Rakitin B; Levy R; Meck WH; Deweer B; Dubois B; Gibbon J
    J Cogn Neurosci; 1998 May; 10(3):316-31. PubMed ID: 9869707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Speed and power of higher cerebral functions in parkinsonian patients.
    Helscher RJ; Pinter MM
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):35-44. PubMed ID: 8439391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parkinsonism: effects of levodopa treatment on concept formation.
    Bowen FP; Kamienny RS; Burns MM; Yahr M
    Neurology; 1975 Aug; 25(8):701-4. PubMed ID: 1171402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The adverse effect of benzhexol on memory in Parkinson's disease.
    Miller E; Berrios GE; Politynska B
    Acta Neurol Scand; 1987 Oct; 76(4):278-82. PubMed ID: 3687379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of levodopa on "frontal" signs in Parkinsonism.
    Morel-Maroger A
    Br Med J; 1977 Dec; 2(6101):1543-4. PubMed ID: 589336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.